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Abstract
Renal cell carcinoma (RCC) in young adults is uncommon. Whether they have different clinicopathologic
characteristics and outcomes from those in older patients is still a conflicting matter. In this article we
present an uncommon subtype of RCC which is chromophobe RCC (chRCC) in a female aged less than 20Young adults;
Prognosis years.
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enal cell carcinoma (RCC) is the most common neoplasm of the
idney representing on average over 90% of all renal malignancies
hat occur in adults in both sexes [1,2]. It is rare in the pediatric
opulation and only 2% of RCC occur in patients younger than 20
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ears old [3]. RCC is a heterogeneous disease comprised of different
istological variants including clear cell, papillary, chromophobe,
ollecting duct, medullary, MiT translocation renal cell carcinoma
TRCC), mucinous tubular spindle cell and unclassified, according
o the World Health Organization (WHO) classification. It is known
hat the most common subtype in adulthood is clear cell followed
y papillary then chromophobe RCC (chRCC). But in the pediatric
opulation, TRCC comprises the majority of RCC [4,5]. The fre-
uency of the remaining non-translocation associated RCCs in this
ge group is still a matter of controversy. In this paper we present a
ase of a chRCC occurring in an 18-year-old female.ase  report
n 18-year-old female, with no medical history, presented with
bdominal pain and distention evolving for 2 months. Clinical
and hosting by Elsevier B.V. This is an open access article under the CC
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Fig.  1  Renal  CT  scan. (a) Renal mass with central calcifications and la
enhancement.
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oFig.  2  Well-delimited kidney tumor with gray-yellowish cut surface.
Presence of foci of necrosis and hemorrhage.
examination revealed a large painless mass in the left abdomen.
Laboratory studies showed anemia with elevated levels of Lactate
dehydrogenase (LDH = 748 UI/l). Ultrasonography confirmed the
presence of the bulky mass in the left hypochondrium. On further
evaluation, the thoraco-abdomino-pelvic computed tomography
(CT) showed a hypervascular large mass (26 cm ×  21 cm ×  17 cm)
arising from the left kidney with central calcifications and necrosis
(Fig. 1). There were no secondary lesions. The patient underwent
a left nephrectomy. Gross examination revealed an encapsulated,
well delimited tumor measuring 23 cm ×  21 cm, occupying almost
the entire kidney. The cut surface of the tumor was gray-yellowish
in color presenting areas of necrosis and hemorrhage (Fig. 2). The
hilar vessels and the ureter were not involved. Histological anal-
ysis of this tumor showed a lobulated carcinomatous proliferation
comprised of groups of polygonal cells with accentuated cell bor-
ders, an irregular nuclei and a perinuclear halo. These cells were
sometimes binucleated or even multinucleated. Their cytoplasm was
either abundant and transparent or granular and eosinophilic. Areas
d
T
mrge foci of necrosis. (b) Post contrast images showing homogeneous
f necrosis, fibrosis and calcification were also seen in this tumor
Fig. 3). There was no invasion of the peri-renal fat or the renal vein.
ale’s colloidal iron stain showed a cytoplasmic positivity (Fig. 4).
mmunohistochemical stain CK7, EMA and CD117 were positive
hile vimentin and CD10 were negative (Fig. 5). Based on these
orphological and immunohistochemical features, the diagnosis of
hromophobe renal cell carcinoma was made. This tumor was classi-
ed as pT2b cN0 cM0 according to the TNM system. After surgery,
he patient made an uneventful recovery. At 23 months of follow up,
here were no sign of disease recurrence or metastasis.
iscussion
he chRCC represents the third most common variant of RCC. It is
n uncommon variant accounting for 5–10% of all cases of RCCs
1]. The mean age of incidence is in the sixth decade with a range
f 27–86 years [2]. Many series of chRCC were reported [6–10].
n those series, all patients were aged more than 20 years. Yet,
ome cases of chRCC in patients aged less than 20 years have been
eported. In a series of 16 cases of chRCC reported by Nakaigawa
t al., the mean age and range of ages of patients were 50.9 years
nd 16–74 years, respectively [11]. Din et al. reported 45 cases of
hRCC and found that age ranged from 18 to 90 years with an aver-
ge age of 48.5 years [12]. Eggener et al. reviewed 119 renal tumors
n patients aged from 17 to 45 years old; they found that 91 (76.5%)
f them are RCCs. The incidence of chRCC was relatively increased
12.1%) in this population [13]. Other authors reported comparative
tudies of RCC between young patients (younger than 40 years)
nd their older counterparts. Suh et al. [14], Thompson et al. [15],
nd Gillett et al. [16] found a higher incidence of chRCC in young
atients compared with the older patients group. Lee et al. [17], as
ell as Taeccoen et al. [18] reported a high proportion of non-clear
ell carcinomas in young adults but the most common variant was
apillary carcinoma. Goetzl et al. [19] did not find any difference in
he frequency of histological subtypes of RCC between young and
ld adults. In our case, the patient’s age was 18 years when she was
iagnosed with chRCC.
here are no specific clinical features of chRCC but the most com-
on symptoms are hematuria, flank mass and pain [1,20].
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Fig.  3  (a) Proliferation of various-sized tumor cells arranged in large sheets separated by fibrovascular septa (HE 100×). (b) The cell border is
thick and prominent. The cytoplasm is eosinophilic and granular. The nucle
halos (HE 400×).
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sig.  4  Hale’s colloidal iron stain positivity in the cytoplasm (400×)
T findings in chRCC show a hypodense mass with a homogeneous
nhancement. Calcifications may be seen in 38% of the cases [1].
n gross examination, chRCC are solid, well circumscribed tumors
ith a lobulated surface that appears grey-beige in color [1,2]. Foci
f necrosis and hemorrhage may also be seen [20]. The mean size of
his tumor is 6 cm [1,21]. In a series of 104 cases of chRCC reported
y Cindolo et al., the tumor size ranged from 1.2 cm to 18 cm [6].
hang et al. reported 42 cases of chRCC ranging in size from 2 cmo 19 cm [7]. Among the 53 cases of chRCC reviewed by Zhao et al.,
he largest tumor size was 20 cm [8]. The tumor size in our case was
3 cm in greatest dimension.
o
s
si are generally wrinkled. Presence of binucleated cells and perinuclear
icroscopically, this neoplasm grows typically in a solid pattern,
ith fibrotic septa and thick-walled blood vessels, and some-
imes in glandular or tubulocystic patterns. It is made of two
ypes of tumor cells in varying proportions. Some are polygo-
al with abundant and clear cytoplasm. Others are small with an
osinophilic and granular cytoplasm. Both cells have in common
harply defined borders, an irregular, wrinkled nuclei and perinu-
lear halos. Some cells are binucleated. Hale’s colloidal iron stain
hows a diffuse and strong cytoplasmic reticular positivity due to
he presence of numerous cytoplasmic vesicles. Immunohistochem-
cal analysis shows a strong and diffusely positive immunostaining
or cytokeratin 7 and epithelial membrane antigen (EMA) with a
egative reaction for CD10 and vimentin [1,2,20]. Our patient pre-
ented the typical histological and immunohistochemical features of
hRCC.
he Fuhrman grading system is useless in chRCC since irregular
uclei, proeminent nucleoli and nuclear pleomorphism are inher-
ntly present in this tumor. Moreover, Paner et al. proposed a novel
-tiered grading system based on the analysis of geographic nuclear
rowding and anaplasia. Paner et al. also concluded the superior
rognostic value of this novel grading system compared to Fuhrman
rade [22,23].
lthough chRCC is known to have a favorable outcome, the prog-
osis of RCC occurring in young adults remains a matter of
ontroversy. In fact, some authors reported a favorable long-term
urvival in young adults with RCC in comparison with a group of
ld adults [14,18]. Others found no difference in cancer specific
urvival between the age groups [15,19]. Lee et al. concluded that
urvival outcomes were poorer in young adults [17].
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[Fig.  5  Immunohistochemistry  study. (a) Positivity of tumor cells w
(c) Tumor cells are negative for Vimentin (200×).
Conclusion
In this paper we report a large ChRCC in an 18-year-old female. The
occurrence of this subtype of RCC in young adults is uncommon. In
this particular age group, the incidence of RCCs in general is rising
and its prognosis compared to older patients is still a conflicting
matter.
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